CODEBASE INVESTMENT ADDS ORAL MUCOSAL PATENT FILING, EXPANDING TRANSDERMAL TREATMENTS
April 23, 2020 12:01 AM
Read more
HYDROXYCHLOROQUINE SIDE EFFECTS POTENTIALLY MITIGATED BY TRANSDERMAL DELIVERY
April 21, 2020 12:05 AM
Read more
HYDROXYCHLOROQUINE TREATMENT FOR COVID-19 BENEFITS SOUGHT IN GLOBAL RESEARCH EFFORT TO ESTABLISH EFFICACY
April 20, 2020 6:30 AM
Read more
CODEBASE VENTURES INC. ANNOUNCES $1.5 MILLION FINANCING AND FIRST CLOSING OF FINANCING
April 16, 2020 2:30 PM
Read more
CODEBASE TO INVEST IN COMPANY DEVELOPING HYDROXYCHLOROQUINE TRANSDERMAL TREATMENT
April 16, 2020 12:01 AM
Read more
CODEBASE PROVIDES UPDATE ON ITS HOLDINGS AND NEAR-TERM INVESTMENT PRIORITIES
April 03, 2020 12:05 AM
Read more
CODE VENTURES INC. EXTENDS EXPIRY DATE OF CERTAIN WARRANTS
March 05, 2020 1:00 PM
Read more
CODEBASE VENTURES INC. CLOSES NON-BROKERED PRIVATE PLACEMENT
February 25, 2020 3:02 PM
Read more
CODE FINALIZES STRATEGIC INVESTMENT IN MOBILE GAME APP TRAD3R
February 20, 2020 12:01 AM
Read more
ARCOLOGY LAUNCHES TESTING OF ETHEREUM APPLICATIONS
February 19, 2020 12:05 AM
Read more
